|Bid||0.00 x 800|
|Ask||0.00 x 1100|
|Day's Range||187.58 - 195.00|
|52 Week Range||115.03 - 217.25|
|Beta (5Y Monthly)||1.69|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 22, 2023 - Feb 27, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||207.29|
Moderna (MRNA) closed the most recent trading day at $193.24, moving +0.09% from the previous trading session.
Equity markets are entirely unpredictable in the short run. The biotech industry is a great place to look for stocks that can survive down markets and be successful over long periods since the drugs these companies develop are so critical to their customers' lives. Let's look at two biotech stocks to buy today and hold on to for a while: Amgen (NASDAQ: AMGN) and Moderna (NASDAQ: MRNA).
Despite being one of the few authorized COVID-19 vaccine makers in the United States, Novavax's (NVAX) vaccine struggles for market share.